Columbus City Attorney Zach Klein announced that the city has filed a lawsuit against several drug companies and pharmacy ...

This month on pharmaphorum, we explore the history of French pharmaceutical company Sanofi, which was created through many partnerships and acquisitions over a period of 100 years. Sanofi is one ...

However, this is increasingly being shadowed by a growing incidence of lifestyle-related diseases such as hypertension, diabetes and ... Remaining MNCs include Sanofi Aventis (#13th Rank ...

Clarius Group LLC lifted its holdings in shares of Sanofi (NASDAQ:SNY – Free Report) by 11.9% in the fourth quarter, ...

After hitting a regulatory roadblock in 2022, Sanofi’s consumer healthcare business Opella has secured the FDA’s blessing to ...

Frexalimab is under clinical development by Sanofi and currently in Phase II for Type 1 Diabetes (Juvenile Diabetes). According to GlobalData, Phase II drugs for Type 1 Diabetes (Juvenile Diabetes) ...

A new study has considered some of the potential benefits and risks of glucagon-like peptide 1 receptor agonists (GLP-1RAs), ...

Sanofi India Ltd. key Products/Revenue Segments include Pharmaceutical Products, Sale of services, Other Operating Revenue, Export Incentives and Scrap for the year ending 31-Dec-2023.For the quarter ...

The acute coronary syndrome market is experiencing significant growth, driven by the increasing prevalence of both acute ...

After hours: January 17 at 5:07:01 p.m. EST ...

After hours: 7:37:35 pm GMT-5 ...